Schedule 13G ownership disclosure

DIANTHUS THERAPEUTICS INC COM

Security class unavailable · CUSIP: 55910K108

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.0900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-103011
Form type
SC 13G
Filer
Dianthus Therapeutics, Inc. /DE/
CIK
CIK 1690585
Filed
Sep 26, 2022
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub